These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4997816)

  • 21. Rifampin in initial treatment of advanced pulmonary tuberculosis.
    Corpe RF; Sanchez ES
    Chest; 1972 Jun; 61(6):564-73. PubMed ID: 5032152
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis.
    Curry FJ
    Chest; 1973 Apr; 63(4):536-46. PubMed ID: 4633013
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 24. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 25. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results with rifampicin together with ethambutol and-or other drugs in the treatment of tuberculosis with cultures resistant to the standard drugs.
    Pines A
    Respiration; 1971; 28():Suppl:91-6. PubMed ID: 5004832
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 29. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
    Hetrick C; Ras R; Turri M
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1830-3. PubMed ID: 5453003
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and management of tuberculosis.
    Harris AA; Karakusis P
    Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
    Bobarykin VS
    Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
    Kohno S; Koga H; Kaku M; Maesaki S; Hara K
    Chest; 1992 Dec; 102(6):1815-8. PubMed ID: 1446494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis.
    Nitti V
    Respiration; 1971; 28():Suppl:57-69. PubMed ID: 4948629
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056
    [No Abstract]   [Full Text] [Related]  

  • 39. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):39-45. PubMed ID: 4979932
    [No Abstract]   [Full Text] [Related]  

  • 40. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.